Mercy Research St Louis

St Louis, Missouri 63141

0 studies enrolling now · 3 studies all time

What they study most

Acute Non-cardioembolic Ischemic Stroke, High-risk Transient Ischemic Attack, Infectious Pneumonia, Prevention of Ischemic Stroke, Severe COVID-19, Small-Cell Lung Cancer

Studies at this site

• A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer — Running, not enrolling
• Reparixin add-on Therapy to Standard Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia — Stopped early
• A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke — Completed